Opinion: Diagnostics Needed

Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.

Written byMark Kessel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, PHR-ISRAELThe greatest obstacle to the care and control of diseases in the developing world is the absence of accurate and affordable diagnostic tests. This deficit can cause delayed diagnosis that lead to less effective and more expensive treatments, as well as the spread of disease to others. Worse, lack of sufficient diagnostics can result in misdiagnoses, improper treatment, and sometimes death. And even when diagnostics are available, they are often too costly, or at least more costly than the drugs to treat a perceived disease, further contributing to drug resistance. The net effect is endangered lives, wasted resources, and the potential to create an even bigger health problem.

There are many challenges to achieving a successful diagnostic. Being inexpensive alone is not sufficient. It also has to be able to perform to high standards in challenging settings, such as villages across much of Africa where a small percentage of health facilities have access to a reliable power supply or towns and villages in the Indian subcontinent where operating temperatures are regularly above 40°C. As a result, such tests have to be affordable, sensitive, specific, user-friendly, robust and rapid, equipment-free, and deliverable (ASSURED tests). Given all these challenges, developing new diagnostics for resource limited settings continues to be underfunded.

The potential to create inexpensive and effective diagnostic tests from a technological point of view should be achievable, however. For example multiple tests for malaria ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A photograph of Mark Kessel

    Mark Kessel is an advisor to biotech companies and academic medical centers. He was previously a founder of Symphony Capital and the Managing Partner of Shearman & Sterling.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH